Author

Zahid Rasool Lone

Institution: Central Drug Research Institute

Observed institution: Central Drug Research Institute

OpenAlex ID: A5085294522

Pyrroloquinoline quinone (PQQ) improves pulmonary hypertension by regulating mitochondrial and metabolic functions

2022 · Mohammad Shafiq, Zahid Rasool Lone, et al. · Pulmonary Pharmacology & Therapeutics · 16

Ormeloxifene, a selective estrogen receptor modulator, protects against pulmonary hypertension

2023 · Adam Olaitan Abdulkareem, Priya Tiwari, et al. · European Journal of Pharmacology · 15

Involvement of mitogen-activated protein kinase (MAPK)-activated protein kinase 2 (MK2) in endothelial dysfunction associated with pulmonary hypertension

2021 · Mohammad Shafiq, Zahid Rasool Lone, et al. · Life Sciences · 7

Inhibition of poly (ADP-ribose) Polymerase-1 (PARP-1) improves endothelial function in pulmonary hypertension

2023 · Mohammad Shafiq, Zahid Rasool Lone, et al. · Pulmonary Pharmacology & Therapeutics · 6

Corrigendum to “Ormeloxifene, a selective estrogen receptor modulator, protects against pulmonary hypertension” [Eur. J. Pharmacol. 943 (2023) 175558]

2023 · Adam Olaitan Abdulkareem, Priya Tiwari, et al. · European Journal of Pharmacology · 1

Ormeloxifene alleviates pulmonary hypertension in monocrotaline-treated male Sprague-Dawley rats

2026 · Adam Olaitan Abdulkareem, Zahid Rasool Lone, et al. · Egyptian Journal of Basic and Applied Sciences

Works count: 6

Citation count: 45

H-index: 4

I10-index: 2